A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).
Expert Opinion on Therapeutic Patents.
2023,
33(2),
67-87,
ISSN: 1354-3776,
PMID: 36975020,